165 related articles for article (PubMed ID: 28345442)
21. Alignment of diagnosis and pharmacy claims data coding of medication adherence among patients with diabetes or hypertension.
Gatwood J; Hohmeier KC; Shuvo S; Mikaiel D; Kovesdy CP
J Manag Care Spec Pharm; 2021 Apr; 27(4):497-506. PubMed ID: 33769854
[No Abstract] [Full Text] [Related]
22. Primary nonadherence to statin medications in a managed care organization.
Cheetham TC; Niu F; Green K; Scott RD; Derose SF; Vansomphone SS; Shin J; Tunceli K; Reynolds K
J Manag Care Pharm; 2013 Jun; 19(5):367-73. PubMed ID: 23697474
[TBL] [Abstract][Full Text] [Related]
23. Evaluating the Impact of Sample Medication on Subsequent Patient Adherence.
Pringle JL; Aldridge A; Kearney SM; Grasso K; Radack J; Hogue S; Manolis C
J Manag Care Spec Pharm; 2016 Nov; 22(11):1262-1269. PubMed ID: 27783544
[TBL] [Abstract][Full Text] [Related]
24. Factors associated with medication nonadherence among Medicare low-income subsidy beneficiaries with diabetes, hypertension, and/or heart failure.
Steve Tsang CC; Browning J; Todor L; Dougherty S; Hohmeier KC; Sam Li M; Borja-Hart N; Hines LE; Wang J
J Manag Care Spec Pharm; 2021 Aug; 27(8):971-981. PubMed ID: 34337985
[No Abstract] [Full Text] [Related]
25. Treatment Initiation Patterns, Modifications, and Medication Adherence Among Newly Diagnosed Heart Failure Patients: A Retrospective Claims Database Analysis.
Deschaseaux C; McSharry M; Hudson E; Agrawal R; Turner SJ
J Manag Care Spec Pharm; 2016 May; 22(5):561-71. PubMed ID: 27123917
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of statin utilization and adherence among privately insured subjects in the Commonwealth of Puerto Rico.
Hernández-Muñoz JJ; Wong ES; Kamdar CR
J Manag Care Spec Pharm; 2021 Mar; 27(3):392-398. PubMed ID: 33645248
[No Abstract] [Full Text] [Related]
27. Effect of the ExactCare medication care management model on adherence, health care utilization, and costs.
Shetty KD; Chen AY; Rose AJ; Liu HH
J Manag Care Spec Pharm; 2021 May; 27(5):574-585. PubMed ID: 33560167
[No Abstract] [Full Text] [Related]
28. Can purchasing information be used to predict adherence to cardiovascular medications? An analysis of linked retail pharmacy and insurance claims data.
Krumme AA; Sanfélix-Gimeno G; Franklin JM; Isaman DL; Mahesri M; Matlin OS; Shrank WH; Brennan TA; Brill G; Choudhry NK
BMJ Open; 2016 Nov; 6(11):e011015. PubMed ID: 28186924
[TBL] [Abstract][Full Text] [Related]
29. The impact of manufacturer coupon use in the statin market.
Daugherty JB; Maciejewski ML; Farley JF
J Manag Care Pharm; 2013; 19(9):765-72. PubMed ID: 24156645
[TBL] [Abstract][Full Text] [Related]
30. Statin Adherence Rates in Patients Utilizing a Patient-Centered Medical Home-Based Pharmacy.
Slazak EM; Kozakiewicz JT; Winters NS; Smith JR; Monte SV
J Pharm Pract; 2017 Oct; 30(5):516-520. PubMed ID: 27599748
[TBL] [Abstract][Full Text] [Related]
31. Evaluating the relationship between quality measure adherence definitions and economic outcomes in commercial health plans: a retrospective diabetes cohort study.
Chinthammit C; Axon DR; Mollon L; Taylor AM; Pickering M; Black H; Warholak T; Campbell PJ
J Manag Care Spec Pharm; 2021 Jan; 27(1):64-72. PubMed ID: 33377445
[No Abstract] [Full Text] [Related]
32. Register-based predictors of adherence among new statin users in Finland.
Aarnio EJ; Martikainen JA; Helin-Salmivaara A; Huupponen RK; Hartikainen JE; Peura PK; Korhonen MJ
J Clin Lipidol; 2014; 8(1):117-25. PubMed ID: 24528692
[TBL] [Abstract][Full Text] [Related]
33. A prediction model for nonpersistence or nonadherence to direct oral anticoagulants in hospitalized patients with atrial fibrillation.
Wirbka L; Ruff C; Haefeli WE; Meid AD
J Manag Care Spec Pharm; 2022 Oct; 28(10):1161-1172. PubMed ID: 36125062
[No Abstract] [Full Text] [Related]
34. Predicting adherence trajectory using initial patterns of medication filling.
Franklin JM; Krumme AA; Shrank WH; Matlin OS; Brennan TA; Choudhry NK
Am J Manag Care; 2015 Sep; 21(9):e537-44. PubMed ID: 26618441
[TBL] [Abstract][Full Text] [Related]
35. Patient, physician, and payment predictors of statin adherence.
Chan DC; Shrank WH; Cutler D; Jan S; Fischer MA; Liu J; Avorn J; Solomon D; Brookhart MA; Choudhry NK
Med Care; 2010 Mar; 48(3):196-202. PubMed ID: 19890219
[TBL] [Abstract][Full Text] [Related]
36. Impact of prescription size on statin adherence and cholesterol levels.
Batal HA; Krantz MJ; Dale RA; Mehler PS; Steiner JF
BMC Health Serv Res; 2007 Oct; 7():175. PubMed ID: 17961256
[TBL] [Abstract][Full Text] [Related]
37. Impact of the 2013 Cholesterol Guideline on Patterns of Lipid-Lowering Treatment in Patients with Atherosclerotic Cardiovascular Disease or Diabetes After 1 Year.
Tran JN; Kao TC; Caglar T; Stockl KM; Spertus JA; Lew HC; Solow BK; Chan PS
J Manag Care Spec Pharm; 2016 Aug; 22(8):901-8. PubMed ID: 27459652
[TBL] [Abstract][Full Text] [Related]
38. A retrospective cohort study evaluating the relationship between statin medication adherence and economic outcomes in commercial health plans.
Chinthammit C; Axon DR; Anderson S; Lott B; Taylor AM; Pickering M; Black H; Warholak T; Campbell PJ
J Clin Lipidol; 2020; 14(6):791-798. PubMed ID: 33011136
[TBL] [Abstract][Full Text] [Related]
39. Impact of Out-of-Pocket Pharmacy Costs on Branded Medication Adherence Among Patients with Type 2 Diabetes.
Bibeau WS; Fu H; Taylor AD; Kwan AY
J Manag Care Spec Pharm; 2016 Nov; 22(11):1338-1347. PubMed ID: 27783549
[TBL] [Abstract][Full Text] [Related]
40. Adherence to High-Intensity Statins Following a Myocardial Infarction Hospitalization Among Medicare Beneficiaries.
Colantonio LD; Huang L; Monda KL; Bittner V; Serban MC; Taylor B; Brown TM; Glasser SP; Muntner P; Rosenson RS
JAMA Cardiol; 2017 Aug; 2(8):890-895. PubMed ID: 28423147
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
